Aperion Biologics Invited to Present at the UBS Global Life Sciences Conference

16 September 2011

Aperion Biologics, Inc. announced today that the company will be presenting at the 2011 UBS Global Life Sciences Conference at the Grand Hyatt New York on Wednesday, September 21, 2011 at 3:00 PM (EDT). Daniel Lee, Chief Executive Officer, is scheduled to present an overview of the Company's unique technology, clinical progress and plans for commercialization.